Circulation




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System

Joseph J. Maleszewski, Phillip M. Young, Michael J. Ackerman, Marc K. Halushka

doi : 10.1161/CIRCULATIONAHA.120.051362

Circulation. 2021 | Volume 143, Issue 13: 1271–1273

Buy The Package and View The Article Online


Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device

John R. Giudicessi, Matthew Schram, J. Martijn Bos, Conner D. Galloway, Jacqueline B. Shreibati, Patrick W. Johnson, Rickey E. Carter, Levi W. Disrud, Robert Kleiman, Zachi I. Attia, Peter A. Noseworthy, Paul A. Friedman, David E. Albert, Michael J. Ackerman

doi : 10.1161/CIRCULATIONAHA.120.050231

Circulation. 2021 | Volume 143, Issue 13: 1274–1286

Heart rate–corrected QT interval (QTc) prolongation, whether secondary to drugs, genetics including congenital long QT syndrome, and/or systemic diseases including SARS-CoV-2–mediated coronavirus disease 2019 (COVID-19), can predispose to ventricular arrhythmias and sudden cardiac death. Currently, QTc assessment and monitoring relies largely on 12-lead electrocardiography. As such, we sought to train and validate an artificial intelligence (AI)–enabled 12-lead ECG algorithm to determine the QTc, and then prospectively test this algorithm on tracings acquired from a mobile ECG (mECG) device in a population enriched for repolarization abnormalities.

Buy The Package and View The Article Online


Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation–Related Stroke

Sushravya Raghunath, John M. Pfeifer, Alvaro E. Ulloa-Cerna, Arun Nemani, Tanner Carbonati, Linyuan Jing, David P. vanMaanen, Dustin N. Hartzel, Jeffery A. Ruhl, Braxton F. Lagerman, Daniel B. Rocha, Nathan J. Stoudt, Gargi Schneider, Kipp W. Johnson, Noah Zimmerman, Joseph B. Leader, H. Lester Kirchner, Christoph J. Griessenauer, Ashraf Hafez, Christopher W. Good, Brandon K. Fornwalt, Christopher M. Haggerty

doi : 10.1161/CIRCULATIONAHA.120.047829

Circulation. 2021 | Volume 143, Issue 13: 1287–1298

Atrial fibrillation (AF) is associated with substantial morbidity, especially when it goes undetected. If new-onset AF could be predicted, targeted screening could be used to find it early. We hypothesized that a deep neural network could predict new-onset AF from the resting 12-lead ECG and that this prediction may help identify those at risk of AF-related stroke.

Buy The Package and View The Article Online


Trusting Magic

Michael A. Rosenberg

doi : 10.1161/CIRCULATIONAHA.121.053733

Circulation. 2021 | Volume 143, Issue 13: 1299–1301

Buy The Package and View The Article Online


Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression

Anthony M. Gacita, Dominic E. Fullenkamp, Joyce Ohiri, Tess Pottinger, Megan J. Puckelwartz, Marcelo A. Nobrega, Elizabeth M. McNally

doi : 10.1161/CIRCULATIONAHA.120.050432

Circulation. 2021 | Volume 143, Issue 13: 1302–1316

Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability.

Buy The Package and View The Article Online


Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction

J. Caleb Snider, Lance A. Riley, Noah T. Mallory, Matthew R. Bersi, Prachi Umbarkar, Rekha Gautam, Qinkun Zhang, Anita Mahadevan-Jansen, Antonis K. Hatzopoulos, Luc Maroteaux, Hind Lal, W. David Merryman

doi : 10.1161/CIRCULATIONAHA.120.051517

Circulation. 2021 | Volume 143, Issue 13: 1317–1330

Myocardial infarction (MI) induces an intense injury response that ultimately generates a collagen-dominated scar. Although required to prevent ventricular rupture, the fibrotic process is often sustained in a manner detrimental to optimal recovery. Cardiac myofibroblasts are the cells tasked with depositing and remodeling collagen and are a prime target to limit the fibrotic process after MI. Serotonin 2B receptor (5-HT2B) signaling has been shown to be harmful in a variety of cardiopulmonary pathologies and could play an important role in mediating scar formation after MI.

Buy The Package and View The Article Online


Flash Pulmonary Edema in a 70-Year-Old Man

Katherine Lutz, Cassie Mullen, Liat Litwin

doi : 10.1161/CIRCULATIONAHA.121.053333

Circulation. 2021 | Volume 143, Issue 13: 1331–1334

Buy The Package and View The Article Online


Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy

Syed Bukhari, Amr F. Barakat, Yvonne S. Eisele, Ricardo Nieves, Sandeep Jain, Samir Saba, William P. Follansbee, Amy Brownell, Prem Soman

doi : 10.1161/CIRCULATIONAHA.120.052136

Circulation. 2021 | Volume 143, Issue 13: 1335–1337

Buy The Package and View The Article Online


Multiple Biomarker Approach to Risk Stratification in COVID-19

Nathaniel R. Smilowitz, Vuthy Nguy, Yindalon Aphinyanaphongs, Jonathan D. Newman, Yuhe Xia, Harmony R. Reynolds, Judith S. Hochman, Glenn I. Fishman, Jeffrey S. Berger

doi : 10.1161/CIRCULATIONAHA.120.053311

Circulation. 2021 | Volume 143, Issue 13: 1338–1340

Buy The Package and View The Article Online


Letter by Angiolillo et al Regarding Article, “Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial”

Dominick J. Angiolillo, Deepak L. Bhatt, Gregg W. Stone

doi : 10.1161/CIRCULATIONAHA.120.050205

Circulation. 2021 | Volume 143, Issue 13: e795–e796

Buy The Package and View The Article Online


Response by Gargiulo et al to Letter Regarding Article, “Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial”

Giuseppe Gargiulo, Michael Nagler, Marco Valgimigli

doi : 10.1161/CIRCULATIONAHA.120.051945

Circulation. 2021 | Volume 143, Issue 13: e797–e798

Buy The Package and View The Article Online


Correction to: Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

doi : 10.1161/CIR.0000000000000971

Circulation. 2021 | Volume 143, Issue 13: e799

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?